TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS) (TakeCharge)
Telephone Delivered Self-management Intervention for People With Multiple Sclerosis Addressing Pain, Fatigue, Depression, and Cognitive Difficulties
The proposed project will evaluate the efficacy of a telephone-delivered self-management (T-SM) intervention for reducing the impact of secondary conditions in persons with multiple sclerosis (MS), including chronic pain, fatigue, depression, and cognitive impairment. It is hypothesized that if the effects of these conditions are reduced, study participants will demonstrate improved participation in the community and improved employment outcomes. This project is important because the majority of persons with MS experience one or more of the following secondary conditions: fatigue, pain, depression, and cognitive impairment. These secondary conditions are not always readily apparent and constitute what has been described by our Rehabilitation Research and Training Center as "hidden disabilities." Secondary conditions such as pain, depression, fatigue, and cognitive impairment frequently not only cause distress in their own right but also affect employment, participation, and quality of life. Having more than one often compounds the effect; the effect of all may be greater than the sum of each individually (e.g. depression can worsen fatigue, and cognitive impairment can worsen depression).
It is critical that this constellation of secondary symptoms be addressed using state of the art techniques based on self-management training and that intervention effects be documented with carefully controlled treatment efficacy studies.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
Washington
-
Seattle, Washington, Forente stater, 98195
- University of Washington
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Must be diagnosed with MS by a physician.
- Must be at least 18 years of age.
- Must be able to understand, speak, and read English.
- Must have the presence of at least one of four common secondary conditions (fatigue, pain, depression, cognitive difficulties) that interferes with employment, participation, and functioning.
Exclusion Criteria:
- Unable to understand or read English.
- Severe cognitive impairment, defined as one or more errors on the 6-item screener, that would prevent informed consent and inability to carry on a phone conversation.
- Currently participating in regularly scheduled psychotherapy.
- Psychiatric contraindications such as current psychosis, active suicidal ideation, or current alcohol or drug use.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Self-management Intervention
Telephone based self management intervention targeted at pain, fatigue, depression, and cognitive difficulties.
|
Brief counseling technique, self-management,
|
|
Aktiv komparator: Education
Education about pain, fatigue, depression, and cognitive difficulties in multiple sclerosis.
|
Educational information about pain, fatigue, depression, and cognitive difficulties in multiple sclerosis.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
PHQ 9
Tidsramme: Baseline, 5 weeks, 10 weeks, 6 months, and 12 months
|
Baseline, 5 weeks, 10 weeks, 6 months, and 12 months
|
|
Brief Pain Inventory
Tidsramme: Baseline, 5 weeks, 10 weeks, 6 months, and 12 months
|
Baseline, 5 weeks, 10 weeks, 6 months, and 12 months
|
|
Modified Fatigue Impact Scale
Tidsramme: Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
PROMIS Depression Short Form
Tidsramme: Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
|
PROMIS Pain Impact Short Form
Tidsramme: Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
|
PROMIS Fatigue Short Form
Tidsramme: Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
Baseline, 5 weeks, 10 weeks, 6 months, 12 months
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Dawn Ehde, PhD, University of Washington
- Studieleder: George Kraft, MD, University of Washington
Publikasjoner og nyttige lenker
Generelle publikasjoner
- Knowles LM, Arewasikporn A, Kratz AL, Turner AP, Alschuler KN, Ehde DM. Early Treatment Improvements in Depression Are Associated With Overall Improvements in Fatigue Impact and Pain Interference in Adults With Multiple Sclerosis. Ann Behav Med. 2021 Aug 23;55(9):833-843. doi: 10.1093/abm/kaaa102.
- Ehde DM, Arewasikporn A, Alschuler KN, Hughes AJ, Turner AP. Moderators of Treatment Outcomes After Telehealth Self-Management and Education in Adults With Multiple Sclerosis: A Secondary Analysis of a Randomized Controlled Trial. Arch Phys Med Rehabil. 2018 Jul;99(7):1265-1272. doi: 10.1016/j.apmr.2017.12.012. Epub 2018 Jan 11.
- Ehde DM, Elzea JL, Verrall AM, Gibbons LE, Smith AE, Amtmann D. Efficacy of a Telephone-Delivered Self-Management Intervention for Persons With Multiple Sclerosis: A Randomized Controlled Trial With a One-Year Follow-Up. Arch Phys Med Rehabil. 2015 Nov;96(11):1945-58.e2. doi: 10.1016/j.apmr.2015.07.015. Epub 2015 Aug 6.
Hjelpsomme linker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 36021-C
- H133B080025 (Annet stipend/finansieringsnummer: NIDRR)
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Multippel sklerose
-
BiogenGodkjent for markedsføringSuperoxide Dismutase 1-Amyotropic Lateral SclerosisForente stater
Kliniske studier på Self-management intervention
-
Arizona State UniversityHand Therapy PartnersFullførtDiabetes mellitus, type 2 | SukkersykeForente stater
-
Shifa Tameer-e-Millat UniversityFullført
-
University of FloridaRekrutteringKorsryggsmerter, mekanisk | Akutt smerteForente stater
-
University of Wisconsin, MilwaukeeFullførtKronisk sykdom | Medisinoverholdelse
-
University of MichiganNational Institutes of Health (NIH); National Institute on Aging (NIA); Blue...Fullført
-
VA Office of Research and DevelopmentFullførtObstruktiv søvnapnéForente stater
-
Universiti Teknologi MaraMinistry of Education, MalaysiaHar ikke rekruttert ennåMetabolsk syndrom
-
University of WashingtonNational Institute of Nursing Research (NINR); East Carolina UniversityHar ikke rekruttert ennåImplanterbar defibrillatorbruker | Stressreaksjon | Ptsd | Stressmestring | Sosial kognitiv teoriForente stater
-
Karamanoğlu Mehmetbey UniversityKaraman Training and Research HospitalFullført
-
University of North Carolina, Chapel HillCenters for Disease Control and PreventionFullførtKronisk sykdomForente stater